1. Who Benefits from Neoadjuvant or Adjuvant Hormone Therapy?
Alberto Bossi 
European Urology Supplements 
Volume 8, Issue 12, Pages (December 2009)
DOI: /j.eursup
Copyright © 2009 European Association of Urology Terms and Conditions

2. Fig. 1
Ten-year results of the European Organisation for Research and Treatment of Cancer trial comparing long-term adjuvant hormone therapy plus radiation therapy (RT) with RT alone in patients with locally advanced prostate cancer [10].
OS=overall survival; RT=radiation therapy; HT=hormone therapy.
European Urology Supplements 2009 8, DOI: ( /j.eursup )
Copyright © 2009 European Association of Urology Terms and Conditions

3. Fig. 2
The effect of 3 mo versus 8 mo of neoadjuvant hormone therapy to radiation therapy in patients with clinically localised prostate cancer enrolled in a Canadian multicentre, randomised, controlled phase 3 trial [14].
HT=hormone therapy; RT=radiation therapy; DFS=disease-free survival.
European Urology Supplements 2009 8, DOI: ( /j.eursup )
Copyright © 2009 European Association of Urology Terms and Conditions